Unit 1 Flashcards
Federal government roles (3)
- Safety & Efficacy of new drugs; removal of unsafe dietary supplements
- Equivalency generic and brand
- Place drugs in categories Rx and OTC and schedules
State government roles
Controls who may prescribe drugs via medical/dental board. Controlled substance needs DEA (Drug enforcement admin of department of justice)
Local Government Role
Pass laws that concern drug use in their jurisdiction
Phase 1 clinical trial (Goals, approximate timing, number of volunteers)
<100 healthy males 18-45 yrs
~ 1year
Goals: Determine if it is safe and toxicity/metabolism studies, if animal/human response differ
Phase 2 clinical trial (Goals, approximate timing, number of volunteers)
200-300 patient pools
2 years
Goals: Does it work in patients, safety and efficacy, final dosing, regimen adjust. Detect broader range of toxicity
Phase III clinical trial (Goals, approximate timing, number of volunteers)
1000-6000 patients
~3 years
Goal: Does it work double blind; efficacy, adverse reaction with chronic use
Can be skipped for high need drugs (accelerated/conditional approval)
ANDA Abbreviated new drug application
Generic drugs can bypass clinical trials, just needs to prove bioequivalency
Phase 4 clinical trial (Goals, approximate timing, number of volunteers)
Report adverse effect post marketing surveillance data on mortality/morbidity Other groups - women/older/children Low incidence drug effects missed in phase I-III seen here
Dietary Supplements Define
Taken by mouth. Vitamins/minerals/amino acids/botanical-herbs.
Herbal: Majority of molecular entity pharmaacologic activity not known
Dietary supplement regulation and differ from drugs
Prior to 1994 - assumed safe
No need to prove safe/effective - need reasonable evidence produce is safe.
Sold first, and remove from market if harmful vs proven first, then allowed to sell
Pharmaceutical Equivalence
Same: active ingredient, dosage formulation, rout of adminstration, identical in strength/concentration. “formulation”
Pharmaceutical alternatives
Same therapeutic moiety - differ in salts, ester, complex or dosages/strengths
Bioequivalence
Extent of absorption (bioavailability) and Rate of absorption same for active ingredient. “Formulation –> drug molecules –> Cp –> target”
Therapeutic equivalents
Admin to same individual in same dosage regimen –> same efficacy and safety. Assumed bioequivalent = therapeutically equivalent. “therapeutic effects”
1 gram = ? grains
15.43
1 kg = ? pounds
2.2
1 ounce = ? grains = ? grams
437.5 grains; 28.35 grams
1 drop = ? mL
0.05
1 tsp = ? mL?
5
1 tbsp = ? mL
15
1 fl oz = ? mL
29.56 or “30”
1 quart = ? mL
946
1 pint = ? mL
473
1 gallon = ? L
3.785
HS
at bed time
Stat
immediately
Bid
twice daily
Ac
before meals
Prn
As needed
Tid
three times daily
Qam
every morning
Pc
after meal
IA
intra-arterial
IVPB
IV piggy back
Sc/Sq
subcutaneous
IM
intramuscular
Po
by mouth
Vag
vaginally
Iv
intravenous
Pr
per rectum/rectally
how are drugs scheduled?
Medical use; abuse potential; physiological dependence; psychological dependence
Schedule 1 drugs
No medical use
High abuse potential
High dependence
- Dr cannot prescribe
Schedule 2 drugs
Yes medical use
High abuse
High dependence
- Dr prescribe in ink - cannot phone/fax
Schedule 3 drugs
Yes medical use
Moderate abuse
Mod/high dependence (phys/psych)
- Dr prescribe
Schedule 4 drugs
Yes medical
Low abuse
Low dependence
- Dr prescribe
Schedule 5 drugs
Yes medical
limited abuse
lowest dependence
- Some states do not require prescription but CO does
Legal components of written prescription in CO
Date, ID of prescriber (name, address, license, phone), PT info (name, address), Drug + strength, signature, DEA number
5 parts of dosage regimen
Drug, DOse, Rout, Frequency, Duration
Loading Dose vs Maintenance Dose (purpose and equation)
LD higher to reach desired Cp faster; MD to keep at Cpss
Cp = LD/Vd
MD/T = CL x CPss (T = dosing interval)
Bioavailability F (Definition + Equation)
Extend of absorption of drug from non-intravenous site - used to convert dosage
F = AUC route/AUC IV
Rate of absorption is determined by which 2 factors?
Tmax and Cmax
DIstribution Vd
Drug from plasma to site of action target - extent of drug movement ( dilution factor)
Equation for clearence depends on…
CL = Vd x Ke (elimination rate constant and half life)
Use also to determined interval between dosages to maintain Cpss (MD/T = CL x Cpss)
List routes of administration
Oral, IV, inhalation, Rectal, Sublingual, Intramuscular, Subcutaneous, Transdermal patch, Dermal
Absorption depends on which 4 drug factor
- molecular size - affected by drug -protein binding
- Lipid solubility - O/W
- Degree of ionization - Affected by tissue pH - affects lipid solubility
- Concentration gradient - at site of admin.
Methods to cross lipid bilayers
- Passive diffusion via aqueous channels - water soluble drugs, limit by size
- Passive diffusion via hydrophobic binding - membrane lipids
- Facilitated diffusion - Membrane carrier molecules
- Active transport
Routs of admin fast –> Slow (Oral, IV, Intramuscular, subcutaneous)
IV = Inhalation > intramuscular > subcutaneous > oral
Which routes have high bioavailability
IV, Inhalation, Subligual, Intramuscular, subcutaneous (Transdermal patch)
Routes with low bioavailability
Oral, rectal (varies)
Note: Dermal is NOT systemic
High/low Vd meaning?
Drugs spread to ECF/tissues and longer to eliminate
Drug remains in plasma - quickly eliminated
pH > pKa drug trapping
high pH = basic form dominates - traps acids because WA are ionied, WB is non ion
HH equation
pH = pKa + log A/HA; 10^(pH-pKa) = A/HA
Drug - protein binding effects
Reduce free drug concentration
INcrease half life/prolong drug action - hinders metabolic degradation
reduce excretion
Decrease Vd and ability to enter CNS
Drug Drug interaction concerning if
displaced drug = narrow therapeutic index
displaced drug = starts in high dose
Displaced drug’s Vd = small
Response rate > distribution rate